Clinical trials don’t just advance science; they also serve as in-the-moment treatment options for patients. iClusion is an impact company facilitating access to clinical trials for all stakeholders in the clinical stage of drug development.

Treatments of tomorrow need clinical trials and clinical trials need patients today. iClusion solves the problems of the 2 biggest bottlenecks in drug development Local Study Startup and Patient Recruitment by means of a professional platform named Trial Eye and a public service named Heyleys.

Unique about the iClusion services is that they have been designed from the viewpoint of the 2 most important stakeholders within clinical trials; the patient and their treating physician. If they have easy access to clinical trials and can participate, drug development can speed up. The Footprint iClusion wants to leave on this planet, is changing the lives of patients.

• The professional Trial Eye platform connects study sponsors, study sites, physicians and their patients in a closed-loop ecosystem, providing a harmonized and standardized network infrastructure for local study startup and patient recruitment. Because clinical trials should always be an option!
• Public service Heyleys is committed to giving patients access to information on research with new drugs to discuss these extra treatment options with their own physician. Because research of today is tomorrow’s treatment!